U.S. markets open in 7 hours 6 minutes

Has OncoCyte Changed How We Will Diagnose Cancer in the Near Future?

NEW YORK, NY / ACCESSWIRE / January 30, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on OncoCyte Corporation (NYSE American: OCX) focuses on the development and commercialization of novel and non-invasive blood and urine (liquid biopsy) diagnostic tests for the early detection of cancer.

On Tuesday, January 29, 2019, the company shares soared significantly on news that a study of their cancer diagnosis test indicated positive results.

Detailed report covering OCN products and new study results here READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/oncocyte/

The company is developing diagnostic tests using genetic and protein markers expressed in various types of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer.

Physicians could use OCX tests to eliminate up to three quarters of unnecessary biopsies and their associated complications and deaths. These reduced costs and improved patient outcomes highlight the value proposition for payers such as Medicare and health insurance companies.

Oncocyte pipeline review, analysts' ratings and more available here READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/oncocyte/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source